A Study to Evaluate TENS for Pain Control During Office Cystoscopic Botox Injections


About this study

The purpose of this study is to determine how Transcutaneous Electric Nerve Stimulation (TENS) units affects pain control during office cystoscopic Botox injections and patient satisfaction with the procedure .



Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women ≥ 18 years of age.
  • Scheduled to receive Intradetrusor Onabotulinumtoxin A injection.
  • English speaking.

Exclusion Criteria:

  • Unable or decline to give Informed Consent.
  • Allergy to adhesives.
  • Participant self-report of previous use of TENS Unit or any immediate family member (1st degree relative) who has used a TENS Unit within 1 year prior to study enrollment.
  • Fitted with pacemaker or automatic implanted cardiac defibrillator.
  • History of Epilepsy.
  • Pregnancy and postpartum period (within 12 weeks postpartum).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Occhino, M.D., M.S.

Open for enrollment

Contact information:

Maureen Lemens R.N.

(507) 293-1487


More information


Publications are currently not available